|
|
Volumn 12, Issue 4, 2015, Pages 190-
|
|
Targeted therapies: Hippo effector YAP1 inhibition - Towards a new therapeutic option to overcome drug resistance
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
B RAF KINASE;
B RAF KINASE INHIBITOR;
MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;
PROTEIN INHIBITOR;
RAF INHIBITOR;
RAS PROTEIN;
SHORT HAIRPIN RNA;
TRANSCRIPTION FACTOR YAP1;
UNCLASSIFIED DRUG;
VEMURAFENIB;
MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE;
PHOSPHOPROTEIN;
PROTEIN KINASE INHIBITOR;
PROTEIN SERINE THREONINE KINASE;
SIGNAL TRANSDUCING ADAPTOR PROTEIN;
BRAF GENE;
CANCER PATIENT;
CANCER RESISTANCE;
DRUG RESISTANCE;
DRUG TARGETING;
ENZYME INHIBITION;
HUMAN;
MELANOMA;
NON SMALL CELL LUNG CANCER;
NOTE;
PANCREAS CANCER;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SIGNAL TRANSDUCTION;
TRANSCRIPTION REGULATION;
TREATMENT RESPONSE;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
FEMALE;
GENETICS;
ADAPTOR PROTEINS, SIGNAL TRANSDUCING;
ANIMALS;
FEMALE;
HUMANS;
MAP KINASE KINASE KINASES;
PHOSPHOPROTEINS;
PROTEIN KINASE INHIBITORS;
PROTEIN-SERINE-THREONINE KINASES;
PROTO-ONCOGENE PROTEINS B-RAF;
|
|
EID: 84925956204
PISSN: 17594774
EISSN: 17594782
Source Type: Journal
DOI: 10.1038/nrclinonc.2015.31 Document Type: Note |
|
Times cited : (8)
|
|
References (1)
|
